United States · FDA National Drug Code directory
Naproxen Headache Pain
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50844-471_119e84ef-0042-4a11-8750-ea97837293f6
- Product NDC
- 50844-471
- Form
- TABLET, FILM COATED
- Composition / generic term
- Naproxen Sodium
- Labeler
- L.N.K. International, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200916
- Source listing expiry
- 20271231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 POUCH in 1 CARTON (50844-471-11) / 1 TABLET, FILM COATED in 1 POUCH (50844-471-43) · 50844-471-11
- 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-471-14) · 50844-471-14
- 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-471-16) · 50844-471-16
- 1 BOTTLE, PLASTIC in 1 CARTON (50844-471-19) / 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC · 50844-471-19
- 48 POUCH in 1 CARTON (50844-471-22) / 1 TABLET, FILM COATED in 1 POUCH (50844-471-43) · 50844-471-22
- 25 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-471-56) · 50844-471-56
- 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-471-98) · 50844-471-98
- 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50844-471-99) · 50844-471-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →